Daily Briefing

Around the nation: Novo Nordisk to replace half its board amid leadership shakeup


The Novo Nordisk Foundation, which is Novo Nordisk's largest investor, will replace more than half of the drugmaker's board amid ongoing turmoil at the company, in today's bite-sized hospital and health industry news from Massachusetts, New Jersey, and New York. 

  • Massachusetts: Boston Scientific has entered into a definite agreement to acquire Nalu Medical, a technology company for chronic pain management, for roughly $533 million. According to Modern Healthcare, Boston Scientific has been a strategic investor in Nalu since 2017 and is now acquiring the remaining shares of the company. In 2019, FDA approved Nalu's Nalu Neurostimulation System for targeted relief for adults with severe, unmanageable chronic pain in their shoulder, lower back, knee, and other areas. Nalu Medical is expected to generate over $60 million in sales this year, Boston Scientific said. (Dubinsky, Modern Healthcare, 10/17)
  • New Jersey: The Novo Nordisk Foundation, comprised of Novo Nordisk's largest investors, plans to replace more than half of the company's board, with an extraordinary general meeting of shareholders scheduled for November 14. According to Lars Rebien Sørensen, chair of the foundation, the current board was "too slow in recognizing" changes in the obesity drug market, which led to lagging growth for the Novo's GLP-1 medication Wegovy. Earlier this year, Novo laid off 9,000 workers and replaced its CEO amid underperforming sales. At the meeting, Novo board chair Helge Lund, vice chair Henrik Poulsen, and five independent members will not stand for election. Four employee-elected board members, along with Novo Holdings CEO Kasim Kutay, will remain on the board. The foundation has proposed Sørensen as chair of the board; Cees de Jong, board chair of Novonesis, as vice chair; and Britt Meelby Jensen, Mikael Dolsten, and Stephan Engels as members. The foundation also plans to nominate Helena Saxon and one other person as board members at the board's next regular general meeting in 2026. (Gardner, Biopharma Dive, 10/21)
  • New York: Gov. Kathy Hochul (D) has set aside roughly $2.6 billion to strengthen and modernize electronic health record (EHR) systems for safety net hospitals across New York. The funding will be used for six partnerships between safety net hospitals and healthcare organizations under the Health Care Safety Net Transformation Program, which was established in the fiscal year 2025 Enacted Budget. Some safety net hospitals included in the initiative include Arnot Ogden Medical Center, Crouse Hospital, and Westchester Medical Center. "The strength of our hospitals is a reflection of the strength of our communities, and safety net hospitals play a critical role in providing quality healthcare to vulnerable populations," Hochul said. (Lagasse, Healthcare Finance, 10/22)

Lessons from the C-suite

Browse our library of the "Lessons from the C-suite" series, featuring Advisory Board President Eric Larsen's conversations with the most influential leaders in health care.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

RELATED RESOURCES

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.